Skip to main content

New Products

  • Pampers dresses up baby's bottoms

    CINCINNATI — Pampers has introduced Prints, a limited-edition diaper line.

    Pampers limited-edition Prints are available in designs for both boys and girls, including floral and polka dot prints for girls, and argyle and toy car prints for boys. The diapers can be purchased at retailers nationwide through the summer and are available in sizes 1 through 4.

  • Teva to market generic Combivir tablets

    JERUSALEM — Teva Pharmaceutical Industries is set to market a generic version of an HIV treatment, the drug maker announced Thursday.

    Teva said it will launch generic Combivir tablets (lamivudine and zidovudine) and is eligible for a 180-day period of marketing exclusivity, according to the Food and Drug Administration. The drug maker is expected to ship the drug in fourth quarter 2011, per terms of a settlement agreement between Teva, Glaxo Group and ViiV Healthcare.

  • New Azo product provides PMS relief

    CROMWELL, Conn. — Amerifit Brands on Wednesday launched its Azo PMS product, which has been formulated to help reduce moodiness, irritability and bloating with a variety of ingredients, including high-potency B vitamins, calcium, magnesium, folic acid and two natural herbal blends, the company stated.

  • Mylan launches generic Roxicodone through deal with Coastal Pharmaceuticals

    PITTSBURGH — Mylan has launched a generic version of an opioid painkiller, the company said Wednesday.

    Mylan announced the launch of oxycodone hydrochloride tablets in the 5-mg, 15-mg and 30-mg strengths. Mylan is launching the drug under a development and supply agreement with Coastal Pharmaceuticals.

    The drug is a generic version of Xanodyne’s Roxicodone, a treatment for moderate to severe pain. Oxycodone hydrochloride tablets had sales of about $325 million during the 12-month period ended in March, according to IMS Health.

  • HealthPrize, RealAge look at social media, gaming technology to improve adherence

    SAN DIEGO — HealthPrize Technologies and RealAge will launch a study next month that will test HealthPrize’s medication adherence technologies on patients taking asthma medications, the two companies said Wednesday.

    HealthPrize is the creator of an Internet and mobile app that uses behavioral economics and gaming dynamics to improve medication adherence, while RealAge is a health website that uses the RealAge Test to assess a person’s mortality risk based on health-related factors.

  • HyDrive Energy introduces decaffeinated drink

    RYE, N.Y. — HyDrive Energy is gearing up to debut its caffeine-free energy drink.

    HyDrive Decaf is 100% caffeine- and taurine-free and contains 30 calories per 15.5-oz. bottle. The beverage is available in a Wild Peach variety.

    HyDrive Energy products can be purchased in more than 30,000 retail locations in 44 states and retail for a suggested price range of $1.49 to $1.79 per bottle.

  • Travalo holds fragrances for on-the-go consumers

    BETHESDA, Md. — The latest refillable perfume and cologne atomizer made for on-the-go consumers has hit the market.

    Travalo said its latest model, Travalo Excel, which will retail for $19.99, holds 30% more fragrance (65 sprays) than its original size, the company said. Travalo products, including its Pure and Classic products, retail from $9.99 to $19.99.

  • Taro gets nod to market generic Zyrtec for kids

    HAWTHORNE, N.Y. — The Food and Drug Administration has approved a generic over-the-counter treatment for allergies made by Taro Pharmaceutical Industries.

    Taro announced Monday the approval of cetirizine hydrochloride oral solution.

    The drug, a generic version of Johnson & Johnson’s children’s Zyrtec, is used to relieve symptoms of indoor and outdoor allergies and is available in a sugar-free bubblegum flavor.

X
This ad will auto-close in 10 seconds